DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
164. 眼皮膚白皮症
Oculocutaneous albinism
Clinical trials
/
Disease details
臨床試験数
:
15
/
薬物数
:
54
- (
DrugBank
:
34
) /
標的遺伝子数
:
35
-
標的パスウェイ数
:
141
Search
2 trials found
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT01821781
(
ClinicalTrials.gov
)
March 2013
19/3/2013
Immune Disorder HSCT Protocol
A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduced Intensity Preparatory Regime
A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduc ...
Immune Deficiency Disorders;Severe Combined Immunodeficiency;Chronic Granulomatous Disease;X-linked Agammaglobulinemia;Wiskott-Aldrich Syndrome;Hyper-IgM;DiGeorge Syndrome;Chediak-Higashi Syndrome;Common Variable Immune Deficiency;Immune Dysregulatory Disorders;Hemophagocytic Lymphohistiocytosis;IPEX;Autoimmune Lymphoproliferative Syndrome;X-linked Lymphoproliferative Syndrome
Immune Deficiency Disorders;Severe Combined Immunodeficiency;Chronic Granulomatous Disease;X-linked ...
Drug:
Transplant preparative regimen of
alemtuzumab
, fludarabine, thiotepa, and melphalan
Washington University School of Medicine
NULL
Recruiting
N/A
21 Years
All
20
Phase 2
United States
2
NCT01652092
(
ClinicalTrials.gov
)
September 4, 2012
25/7/2012
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
SCID;Omenn's Syndrome;Reticular Dysgenesis;Wiskott-Aldrich Syndrome;Bare Lymphocyte Syndrome;Common Variable Immunodeficiency;Chronic Granulomatous Disease;CD40 Ligand Deficiency;Hyper IgM Syndrome;X-linked Lymphoproliferative Disease;Hemophagocytic Lymphohistiocytosis;Griscelli Syndrome;Chediak-Higashi Syndrome;Langerhan's Cell Histiocytosis
SCID;Omenn's Syndrome;Reticular Dysgenesis;Wiskott-Aldrich Syndrome;Bare Lymphocyte Syndrome;Common ...
Drug:
Alemtuzumab
0.3 mg
;Drug:
Cyclophosphamide
;Drug:
Busulfan
;Biological:
Stem Cell Transplantation
;Drug:
Fludarabine
phosphate 40 mg
;Drug:
Melphalan
;Drug:
Alemtuzumab
0.2 mg
;Drug:
Fludarabine
phosphate 30 mg
;Drug:
MESNA
Drug:
Alemtuzumab
0.3 mg
;Drug:
Cyclophosphamide
;Drug:
Busulfan
;Biological:
Stem Cell Transplantation
; ...
Masonic Cancer Center, University of Minnesota
NULL
Recruiting
N/A
50 Years
All
30
N/A
United States